Blueprint Medicines Corp Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Blueprint Medicines Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Blueprint Medicines Corp Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $68.9M, a 11.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $68.9M -$8.65M -11.2% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $71.2M -$8.45M -10.6% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $73.7M -$8.16M -9.97% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $75.2M -$8.7M -10.4% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $77.5M -$8.5M -9.89% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $79.7M -$8.45M -9.59% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $81.9M -$8.31M -9.22% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $83.9M +$20.9M +33.2% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $86M +$21.6M +33.5% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $88.1M +$22.1M +33.5% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $90.2M +$22.6M +33.5% Dec 31, 2021 10-K 2023-02-16
Q3 2021 $63M -$6.03M -8.74% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 $64.4M -$6.03M -8.55% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $66M -$5.92M -8.23% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 $67.5M -$5.21M -7.17% Dec 31, 2020 10-K 2022-02-17
Q3 2020 $69M -$4.95M -6.69% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $70.5M -$4.78M -6.36% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $71.9M -$4.63M -6.04% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $72.8M +$18.5M +34.1% Dec 31, 2019 10-K 2021-02-17
Q3 2019 $74M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $75.3M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $76.5M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $54.2M Jan 1, 2019 10-K 2020-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.